VEGFA rs2010963: Understanding Your Genetic Variant
The rs2010963 variant is a common genetic change located within the VEGFA gene. It is widely studied for its potential influence on the body's production of Vascular Endothelial Growth Factor (VEGF), a protein essential for blood vessel formation.
What each genotype means
Baseline VEGF expression
This genotype is associated with baseline levels of Vascular Endothelial Growth Factor (VEGF) production. Research into this variant often examines its role in cancer prognosis and vascular conditions, though findings are frequently mixed and can depend on your specific ancestry or other genetic factors.
This is a common genotype found in many global populations, though exact frequencies vary significantly by ethnic background.
Intermediate VEGF expression
Carrying one copy of the G allele may influence how your body regulates VEGF protein levels. Studies have explored links between this variant and outcomes in conditions like chronic lymphocytic leukemia or myocardial infarction, but these associations are often context-dependent and not diagnostic of any specific health outcome.
This heterozygous genotype is frequently observed across diverse populations worldwide.
Potential altered VEGF expression
This genotype has been studied for its potential influence on VEGF protein secretion and its role in various disease models, including vascular toxicity and cancer progression. Because research findings are often inconsistent or specific to certain clinical subgroups, this result should be viewed as a statistical association rather than a direct indicator of health status.
This genotype is common in many populations, though it is less frequent than the CC or CG genotypes in some ancestral groups.
What is rs2010963?
The rs2010963 variant is a single nucleotide polymorphism (SNP) located in the 5' untranslated region (5' UTR) of the VEGFA gene. In genetic terms, a SNP represents a variation at a single position in the DNA sequence. Because this specific variant sits in a regulatory region of the gene, researchers have long hypothesized that it may influence how the gene is expressed or how much protein is ultimately produced. It is a well-documented marker in genomic databases and is frequently included in studies investigating the genetic architecture of complex traits. By analyzing this specific location on the chromosome, scientists aim to understand how subtle differences in our DNA code might contribute to biological variability between individuals.
The Role of the VEGFA Gene
The VEGFA gene provides instructions for making a protein called Vascular Endothelial Growth Factor A. This protein is a primary signal for angiogenesis, the physiological process through which new blood vessels form from pre-existing ones. VEGF is critical during embryonic development, but it also plays a vital role in wound healing, muscle growth, and the maintenance of healthy blood vessels throughout adulthood. Because of its central role in blood vessel growth, the VEGFA gene is a frequent subject of study in fields ranging from oncology to cardiovascular medicine. When the expression of this gene is altered, it can theoretically impact how the body responds to tissue injury or how it manages blood flow, making it a significant focus for researchers studying vascular health.
Research Associations and Evidence
Scientific literature has explored the association of rs2010963 with various health outcomes, though the evidence is often complex and context-dependent. Studies have investigated its role in conditions such as type 2 diabetes, cardiovascular risk, and even responses to certain medical treatments like bevacizumab in cancer patients. Some research suggests that specific genotypes may correlate with altered serum levels of the VEGF protein, while other studies have looked at its potential as a prognostic factor in chronic conditions. It is important to note that these associations are often observed in specific populations or clinical cohorts, and the strength of the evidence varies significantly across different studies. Because many of these findings are based on observational case-control studies, they demonstrate statistical correlations rather than direct causation, and results can sometimes be mixed or contradictory depending on the ancestry of the study participants.
What You Can Do With This Information
Genetic information like your rs2010963 status is primarily a tool for scientific research and understanding biological diversity. It is not a diagnostic test, and it cannot predict your personal health outcomes or disease risk with certainty. If you have received results regarding this variant, it is important to view them in the context of your overall health, lifestyle, and family history. You cannot use this information to make medical decisions, such as starting or stopping medications or changing your diet. If you are concerned about cardiovascular health, metabolic conditions, or any other health trait mentioned in research, the best course of action is to consult with a qualified healthcare provider. They can help you interpret your health status based on clinical evidence rather than individual genetic markers.
How common is this variant?
The rs2010963 variant is considered a common polymorphism, with its frequency varying across different global populations as documented in large-scale genomic databases.
Frequently asked questions
Is rs2010963 a diagnostic test for disease?
No, rs2010963 is not a diagnostic test. It is a common genetic variant studied for its statistical association with various traits, but it does not determine whether you will develop a specific disease.
Does my genotype for rs2010963 mean I have high or low VEGF levels?
Research has shown mixed results regarding the impact of this variant on protein levels. While some studies suggest a correlation, these findings are often specific to certain populations or clinical conditions and are not universal.
Should I change my medication based on this SNP?
You should never change your medication based on a genetic variant. Always discuss your medications and any genetic information with your doctor or pharmacist before making changes to your treatment plan.
Where can I find more information about VEGFA?
You can find reliable information about the VEGFA gene and its functions on resources like MedlinePlus Genetics or the National Center for Biotechnology Information (NCBI) Gene database.
Sources & further reading
Educational information only, last refreshed 10/8/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs2010963?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in VEGFA
A well-studied promoter/5'-UTR regulatory variant (-634G>C) altering VEGFA expression, associated with circulating VEGF levels and diabetic microvascular risk.
A regulatory variant in the VEGFA locus associated with age-related macular degeneration (AMD) risk and response to anti-VEGF therapy; functional studies suggest it influences VEGFA expression in retinal pigment epithelium.
Promoter polymorphism (-2578C/A) regulating vascular endothelial growth factor expression, linked to proliferative diabetic retinopathy and atherosclerosis.
Functional promoter variant in VEGFA influencing angiogenic expression profiles that modulate risk for preeclampsia and recurrent pregnancy loss.
This polymorphism in the VEGFA gene is studied for its potential impact on the response to anti-VEGF therapy in age-related macular degeneration.
This SNP shows a nominal association with bleeding susceptibility in patients treated with warfarin.